FROM THE JOURNAL CHEST®
“Given improvements in insulin delivery and glucose monitoring, a reassessment of potential benefits of [intensive insulin therapy] should once again be evaluated in a prospective randomized trial,” they wrote.
Dr. Hersh and his coauthors declared no financial or nonfinancial disclosures related to the study.
SOURCE: Hersh AM et al. CHEST 2018. doi: 10.1016/j.chest.2018.04.025.
© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
Dr. Snipe Clinical question: In patients with symptomatic high-grade intracranial atherosclerotic stenosis (ICAS), does the use of a drug-eluting stent (DES) reduce the incidence of in-stent...
Dr. Chevli Clinical question: Which is the better strategy for treatment intensification in older patients with hypertension—maximizing the antihypertensive or adding a new...
Case A 76-year-old man with a medical history of congestive heart failure (CHF) with left ventricular ejection fraction of 30%, hypertension, dyslipidemia, and recent hospitalization for CHF...
Data from a large review support use of D-dimer levels to diagnose PE without imaging.